SCHEMBL21611234

SCHEMBL21611234

CC[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccnc(Oc2ccc(C)c(OC)c2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 3/20 0.42
▸ ADORA3 P0DMS8 2/20 0.39
▸ ABCB1 P08183 2/20 0.39
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HPGD P15428 2/20 0.36
▸ CTSS P25774 2/20 0.36
▸ CTSK P43235 2/20 0.36
▸ TAS1R3 Q7RTX0 1/20 0.36
▸ TAS1R1 Q7RTX1 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ THRB P10828 1/20 0.36
▸ RET P07949 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ XBP1 P17861 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21581584 0.89 SCN9A (0.42) SCN9AADORA3ABCB1KDM4EALDH1A1
SCHEMBL31089761 0.89 SCN9A (0.42) SCN9AADORA3ABCB1KDM4EALDH1A1
SCHEMBL21611230 0.85 AAK1 (0.39) SCN9AABCB1KDM4EALDH1A1HPGD
SCHEMBL31089812 0.85 SCN9A (0.48) SCN9AADORA3ABCB1CTSSCTSK
SCHEMBL21611225 0.83 RAF1 (0.42) SCN9AAAK1
SCHEMBL21581607 0.82 SCN9A (0.50) SCN9AADORA3ABCB1KDM4EALDH1A1
SCHEMBL21610134 0.82 ADORA3 (0.44) ADORA3ALDH1A1TAS1R3TAS1R1MAPK1
SCHEMBL21610137 0.82 ADORA3 (0.44) ADORA3ALDH1A1TAS1R3TAS1R1MAPK1
SCHEMBL9923870 0.80 HDAC4 (0.41) SCN9AKDM4EALDH1A1CTSSCTSK
SCHEMBL29437978 0.80 HDAC4 (0.41) SCN9AKDM4EALDH1A1CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220112176-A1 SUBSTITUTED-N-HETEROARYL COMPOUNDS AND USES THEREOF BIONOMICS LIMITED (AU) 2022-04-14 — — US disclosed
WO-2020000065-A2 SUBSTITUTED-N-HETEROARYL COMPOUNDS AND USES THEREOF BIONOMICS LIMITED (AU) 2020-01-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220112176-A1 SUBSTITUTED-N-HETEROARYL COMPOUNDS AND USES THEREOF GABRE, GRIN2C, GRIN2A SCN9A 469/4885ADORA3 1506/4885ABCB1 3191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback